Piper Sandler Reaffirms Overweight on Colgate-Palmolive, Sees 18% Upside Post CEO Meeting

Colgate-Palmolive Company (NYSE:CL) is one of the Best Stagflation Stocks to Buy Now. On May 28, Piper Sandler reiterated its Overweight rating on Colgate-Palmolive (NYSE: CL) and held its price target at $109, implying roughly 18% upside from current trading levels. The reaffirmation followed a private meeting with CEO Noel Wallace and Investor Relations head John Faucher, which gave the firm a closer look at the company’s strategic footing.

The conversation focused heavily on how Colgate is steering through the current tariff dynamics, a situation the firm believes the company is handling efficiently and with minimal disruption. Piper Sandler described Colgate as one of the more stable names within its consumer staples coverage, citing its global footprint and shareholder-focused philosophy as core strengths.

The analysts came away with increased confidence in Colgate’s ability to manage international complexity, maintain consistent performance, and stay aligned with its long-standing emphasis on value creation. That blend of steadiness and strategic agility is what continues to anchor their bullish view on the stock.

Colgate-Palmolive Company (NYSE:CL) is a global consumer goods leader specializing in oral care, personal hygiene, and pet nutrition. With iconic brands like Colgate, Palmolive, Tom’s of Maine, and Hill’s Science Diet, its products remain essential even during economic slowdowns, cementing its status as a defensive staple.

While we acknowledge the potential of CL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None.